Dr. Reddy's Laboratories Limited or Bausch Health Companies Inc.: Who Invests More in Innovation?

Dr. Reddy's vs. Bausch Health: R&D Investment Showdown

__timestampBausch Health Companies Inc.Dr. Reddy's Laboratories Limited
Wednesday, January 1, 201424600000012402000000
Thursday, January 1, 201558280000017449000000
Friday, January 1, 201645500000017834000000
Sunday, January 1, 201736600000019551000000
Monday, January 1, 201841400000018265000000
Tuesday, January 1, 201947100000015607000000
Wednesday, January 1, 202045200000015410000000
Friday, January 1, 202146500000016541000000
Saturday, January 1, 202252900000017482000000
Sunday, January 1, 202360400000019381000000
Monday, January 1, 202422873000000
Loading chart...

Unleashing the power of data

Innovation Investment: A Tale of Two Companies

In the competitive world of pharmaceuticals, innovation is the lifeblood of progress. Dr. Reddy's Laboratories Limited and Bausch Health Companies Inc. are two giants in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, Dr. Reddy's has consistently outpaced Bausch Health, investing nearly 3.8 times more in R&D on average. In 2023, Dr. Reddy's allocated approximately 19.4 billion dollars, marking a 56% increase from 2014. Meanwhile, Bausch Health's R&D spending peaked at 604 million dollars in 2023, a 146% rise from its 2014 figures. This disparity highlights Dr. Reddy's commitment to innovation, even as Bausch Health shows steady growth. The data underscores the strategic priorities of these companies, with Dr. Reddy's focusing heavily on pioneering advancements, while Bausch Health maintains a more conservative investment strategy.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025